Validation of six commercially available angiotensin II type 1 receptor antibodies
Acta Biochimica et Biophysica Sinica · 01.05.2025 · 57 (5) · 851-855
DOI: 10.3724/abbs.2024199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 07.01.2025. Verfasst von Bingjie Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
- Beijing Key Laboratory of Metabolic Disorder Related Cardiovascular Disease, Capital Medical University, Beijing 100069, China.
- State Key Laboratory of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 102308, China.
- Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Zitieren
APA
Li, B., Zhang, X., Sun, F., Zhang, X., Liu, H., & Zhang, S. (2025). Validation of six commercially available angiotensin II type 1 receptor antibodies. Acta Biochimica et Biophysica Sinica, 57(5), 851-855. https://doi.org/10.3724/abbs.2024199
Vancouver
Li B, Zhang X, Sun F, Zhang X, Liu H, Zhang S. Validation of six commercially available angiotensin II type 1 receptor antibodies. Acta Biochimica et Biophysica Sinica. 2025;57(5):851-855. doi:10.3724/abbs.2024199
BibTeX
@article{Li2025,
author = {Li, Bingjie and Zhang, Xi and Sun, Fei and Zhang, Xingzhong and Liu, Huirong and Zhang, Suli},
title = {Validation of six commercially available angiotensin II type 1 receptor antibodies},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
volume = {57},
number = {5},
pages = {851--855},
doi = {10.3724/abbs.2024199}
}
EUVIMED